SWK (NASDAQ:SWKH – Get Free Report) is anticipated to release its Q4 2025 resultson Monday, April 6th. Analysts expect SWK to post earnings of $0.5250 per share for the quarter. Parties may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Thursday, March 26, 2026 at 10:00 AM ET.
SWK (NASDAQ:SWKH – Get Free Report) last announced its earnings results on Friday, March 20th. The company reported ($1.59) EPS for the quarter, missing analysts’ consensus estimates of $0.52 by ($2.11). The firm had revenue of $8.69 million for the quarter. SWK had a negative net margin of 6.11% and a positive return on equity of 0.22%.
SWK Stock Performance
NASDAQ SWKH opened at $15.90 on Friday. The company has a debt-to-equity ratio of 0.14, a current ratio of 9.41 and a quick ratio of 9.41. The stock’s 50 day simple moving average is $16.92 and its 200-day simple moving average is $16.61. The company has a market cap of $192.39 million, a PE ratio of 8.55 and a beta of 0.27. SWK has a 1-year low of $13.17 and a 1-year high of $20.49.
Institutional Trading of SWK
Analysts Set New Price Targets
Separately, Weiss Ratings reissued a “hold (c)” rating on shares of SWK in a research note on Monday, December 29th. Two investment analysts have rated the stock with a Hold rating, According to MarketBeat.com, SWK presently has a consensus rating of “Hold” and an average price target of $18.00.
Check Out Our Latest Report on SWK
SWK Company Profile
SWK Holdings Corporation, offers specialty finance and asset management services in the United States. It operates in two segments, Finance Receivables and Pharmaceutical Development. The Finance Receivables segment provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. This segment also offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance.
Further Reading
Receive News & Ratings for SWK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SWK and related companies with MarketBeat.com's FREE daily email newsletter.
